Gabapentin and motor fluctuations in parkinson's disease
Identifieur interne : 005344 ( Main/Exploration ); précédent : 005343; suivant : 005345Gabapentin and motor fluctuations in parkinson's disease
Auteurs : Pedro Chaná [Chili] ; Alejandro De Marinis [Chili] ; Nelson Barrientos [Chili]Source :
- Movement Disorders [ 0885-3185 ] ; 1997-07.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Acetates (therapeutic use), Aged, Amines, Anticonvulsant, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (chemistry), Antiparkinson Agents (standards), Antiparkinson Agents (therapeutic use), Carbidopa (administration & dosage), Carbidopa (chemistry), Carbidopa (standards), Chemotherapy, Cyclohexanecarboxylic Acids, Drug Combinations, Drug Stability, Drug Therapy, Combination, Enzyme Inhibitors (administration & dosage), Enzyme Inhibitors (chemistry), Female, Fluctuations, Gabapentin, Human, Humans, Levodopa (administration & dosage), Levodopa (chemistry), Levodopa (pharmacokinetics), Male, Middle Aged, Motor Activity (drug effects), Motricity, Movement Disorders (drug therapy), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson disease, Solutions, Treatment, Treatment Outcome, gamma-Aminobutyric Acid.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Enzyme Inhibitors, Levodopa.
- chemical , chemistry : Antiparkinson Agents, Carbidopa, Enzyme Inhibitors, Levodopa.
- chemical , pharmacokinetics : Levodopa.
- chemical , standards : Antiparkinson Agents, Carbidopa.
- chemical , therapeutic use : Acetates, Antiparkinson Agents.
- drug effects : Motor Activity.
- drug therapy : Movement Disorders, Parkinson Disease.
- physiopathology : Parkinson Disease.
- Aged, Amines, Cyclohexanecarboxylic Acids, Drug Combinations, Drug Stability, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Solutions, Treatment Outcome, gamma-Aminobutyric Acid.
Url:
DOI: 10.1002/mds.870120421
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 004377
- to stream Istex, to step Curation: 004377
- to stream Istex, to step Checkpoint: 003968
- to stream PubMed, to step Corpus: 004629
- to stream PubMed, to step Curation: 004629
- to stream PubMed, to step Checkpoint: 004655
- to stream Ncbi, to step Merge: 004D54
- to stream Ncbi, to step Curation: 004D54
- to stream Ncbi, to step Checkpoint: 004D54
- to stream PubMed, to step Corpus: 004628
- to stream PubMed, to step Curation: 004628
- to stream PubMed, to step Checkpoint: 004543
- to stream Ncbi, to step Merge: 004D55
- to stream Ncbi, to step Curation: 004D55
- to stream Ncbi, to step Checkpoint: 004D55
- to stream Main, to step Merge: 008373
- to stream PascalFrancis, to step Corpus: 003212
- to stream PascalFrancis, to step Curation: 003612
- to stream PascalFrancis, to step Checkpoint: 003223
- to stream Main, to step Merge: 008578
- to stream Main, to step Curation: 005344
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gabapentin and motor fluctuations in parkinson's disease</title><author><name sortKey="Chana, Pedro" sort="Chana, Pedro" uniqKey="Chana P" first="Pedro" last="Chaná">Pedro Chaná</name></author><author><name sortKey="De Marinis, Alejandro" sort="De Marinis, Alejandro" uniqKey="De Marinis A" first="Alejandro" last="De Marinis">Alejandro De Marinis</name></author><author><name sortKey="Barrientos, Nelson" sort="Barrientos, Nelson" uniqKey="Barrientos N" first="Nelson" last="Barrientos">Nelson Barrientos</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A339952D7B3C9F984F02465C7B3A5024AC77E919</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1002/mds.870120421</idno><idno type="url">https://api.istex.fr/document/A339952D7B3C9F984F02465C7B3A5024AC77E919/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004377</idno><idno type="wicri:Area/Istex/Curation">004377</idno><idno type="wicri:Area/Istex/Checkpoint">003968</idno><idno type="wicri:doubleKey">0885-3185:1997:Chana P:gabapentin:and:motor</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:9251083</idno><idno type="wicri:Area/PubMed/Corpus">004629</idno><idno type="wicri:Area/PubMed/Curation">004629</idno><idno type="wicri:Area/PubMed/Checkpoint">004655</idno><idno type="wicri:Area/Ncbi/Merge">004D54</idno><idno type="wicri:Area/Ncbi/Curation">004D54</idno><idno type="wicri:Area/Ncbi/Checkpoint">004D54</idno><idno type="wicri:doubleKey">0885-3185:1997:Chana P:gabapentin:and:motor</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:9251084</idno><idno type="wicri:Area/PubMed/Corpus">004628</idno><idno type="wicri:Area/PubMed/Curation">004628</idno><idno type="wicri:Area/PubMed/Checkpoint">004543</idno><idno type="wicri:Area/Ncbi/Merge">004D55</idno><idno type="wicri:Area/Ncbi/Curation">004D55</idno><idno type="wicri:Area/Ncbi/Checkpoint">004D55</idno><idno type="wicri:doubleKey">0885-3185:1997:Pappert E:the:stability:of</idno><idno type="wicri:Area/Main/Merge">008373</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:97-0412074</idno><idno type="wicri:Area/PascalFrancis/Corpus">003212</idno><idno type="wicri:Area/PascalFrancis/Curation">003612</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003223</idno><idno type="wicri:doubleKey">0885-3185:1997:Chana P:gabapentin:and:motor</idno><idno type="wicri:Area/Main/Merge">008578</idno><idno type="wicri:Area/Main/Curation">005344</idno><idno type="wicri:Area/Main/Exploration">005344</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gabapentin and motor fluctuations in parkinson's disease</title><author><name sortKey="Chana, Pedro" sort="Chana, Pedro" uniqKey="Chana P" first="Pedro" last="Chaná">Pedro Chaná</name><affiliation wicri:level="1"><country xml:lang="fr">Chili</country><wicri:regionArea>Service of Neurology Hospital DIPRECA Santiago</wicri:regionArea></affiliation></author><author><name sortKey="De Marinis, Alejandro" sort="De Marinis, Alejandro" uniqKey="De Marinis A" first="Alejandro" last="De Marinis">Alejandro De Marinis</name><affiliation wicri:level="1"><country xml:lang="fr">Chili</country><wicri:regionArea>Service of Neurology Hospital DIPRECA Santiago</wicri:regionArea></affiliation></author><author><name sortKey="Barrientos, Nelson" sort="Barrientos, Nelson" uniqKey="Barrientos N" first="Nelson" last="Barrientos">Nelson Barrientos</name><affiliation wicri:level="1"><country xml:lang="fr">Chili</country><wicri:regionArea>Service of Neurology Hospital DIPRECA Santiago</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1997-07">1997-07</date><biblScope unit="vol">12</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="608">608</biblScope><biblScope unit="page" to="608">608</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A339952D7B3C9F984F02465C7B3A5024AC77E919</idno><idno type="DOI">10.1002/mds.870120421</idno><idno type="ArticleID">MDS870120421</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetates (therapeutic use)</term><term>Aged</term><term>Amines</term><term>Anticonvulsant</term><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (chemistry)</term><term>Antiparkinson Agents (standards)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Carbidopa (administration & dosage)</term><term>Carbidopa (chemistry)</term><term>Carbidopa (standards)</term><term>Chemotherapy</term><term>Cyclohexanecarboxylic Acids</term><term>Drug Combinations</term><term>Drug Stability</term><term>Drug Therapy, Combination</term><term>Enzyme Inhibitors (administration & dosage)</term><term>Enzyme Inhibitors (chemistry)</term><term>Female</term><term>Fluctuations</term><term>Gabapentin</term><term>Human</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Levodopa (chemistry)</term><term>Levodopa (pharmacokinetics)</term><term>Male</term><term>Middle Aged</term><term>Motor Activity (drug effects)</term><term>Motricity</term><term>Movement Disorders (drug therapy)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson disease</term><term>Solutions</term><term>Treatment</term><term>Treatment Outcome</term><term>gamma-Aminobutyric Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Carbidopa</term><term>Enzyme Inhibitors</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiparkinson Agents</term><term>Carbidopa</term><term>Enzyme Inhibitors</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en"><term>Antiparkinson Agents</term><term>Carbidopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Acetates</term><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Activity</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Amines</term><term>Cyclohexanecarboxylic Acids</term><term>Drug Combinations</term><term>Drug Stability</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Solutions</term><term>Treatment Outcome</term><term>gamma-Aminobutyric Acid</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Anticonvulsivant</term><term>Chimiothérapie</term><term>Fluctuation</term><term>Gabapentine</term><term>Homme</term><term>Motricité</term><term>Parkinson maladie</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Chili</li></country></list><tree><country name="Chili"><noRegion><name sortKey="Chana, Pedro" sort="Chana, Pedro" uniqKey="Chana P" first="Pedro" last="Chaná">Pedro Chaná</name></noRegion><name sortKey="Barrientos, Nelson" sort="Barrientos, Nelson" uniqKey="Barrientos N" first="Nelson" last="Barrientos">Nelson Barrientos</name><name sortKey="De Marinis, Alejandro" sort="De Marinis, Alejandro" uniqKey="De Marinis A" first="Alejandro" last="De Marinis">Alejandro De Marinis</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005344 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005344 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A339952D7B3C9F984F02465C7B3A5024AC77E919
|texte= Gabapentin and motor fluctuations in parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |